Rosalind, Geninus expand single-cell analysis offerings in Asia

By The Science Advisory Board staff writers

April 15, 2021 -- Rosalind has partnered with Geninus and HeLiXrUs to enable a new single-cell data analysis solution for cancer researchers in Asia.

Rosalind will combine its platform with Geninus' Celinus single-cell RNA sequencing services to provide expanded analysis and interpretation of data, as well as sharing and collaboration across labs and geographies. The integrated analysis offering is now available to clinicians, academic researchers, and pharmaceutical companies in South Korea and other Asian markets.

Celinus allows direct measurement of gene expression and genetic alteration with single-cell resolution to quantify intracellular heterogeneity and characterize cell types, states, and cellular transition dynamics. It can support single-cell gene expression, single-cell immune profiling, single-nucleus gene expression, single-cell multiome ATAC, and spatial gene expression from the 10X Genomics platform.

HeLiXrUs is a channel partnership company formed to help establish the relationship between Rosalind and Geninus.

Rosalind launches web-based SARS-CoV-2 variant tracker
Rosalind has launched a web-based platform called Rosalind Diagnostic Monitoring for tracking SARS-CoV-2 variants and evaluating their effects on diagnostic...

Copyright © 2021

BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter